Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Increasing demand for nutraceuticals and dietary supplements
3.2.1.2 Growth of pharmaceutical industry
3.2.1.3 Preference for capsule-based dosage forms
3.2.2 Industry pitfalls & challenges
3.2.2.1 Quality control and consistency
3.2.2.2 High production costs
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Future market trends
3.7 Porter’s analysis
3.8 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Type, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Gelatin
5.2.1 Porcine gelatin
5.2.2 Bovine derived
5.2.3 Bone meal
5.2.4 Other gelatin capsule types
5.3 Non-gelatin
5.3.1 Hydroxypropyl methylcellulose (HPMC)
5.3.2 Pullulan & starch
Chapter 6 Market Estimates and Forecast, By Functionality, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Immediate release
6.3 Sustained release
6.4 Delayed release
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Antibiotic and antibacterial drugs
7.3 Vitamins and dietary supplements
7.4 Antacid and anti-flatulent preparations
7.5 Anti-anemic preparations
7.6 Anti-inflammatory drugs
7.7 Cardiovascular therapy drugs
7.8 Cough and cold drugs
7.9 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Pharmaceutical
8.3 Nutraceutical
8.4 Other end users
Chapter 9 Market Estimates and Forecast, By Region, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 North America
9.2.1 U.S.
9.2.2 Canada
9.3 Europe
9.3.1 Germany
9.3.2 UK
9.3.3 France
9.3.4 Italy
9.3.5 Spain
9.3.6 Netherlands
9.4 Asia Pacific
9.4.1 China
9.4.2 Japan
9.4.3 India
9.4.4 Australia
9.4.5 South Korea
9.5 Latin America
9.5.1 Brazil
9.5.2 Mexico
9.5.3 Argentina
9.6 Middle East and Africa
9.6.1 South Africa
9.6.2 Saudi Arabia
9.6.3 UAE
Chapter 10 Company Profiles
10.1 ACG
10.2 BioCaps Enterprise
10.3 Bright Pharma Caps
10.4 CapsCanada Corporation
10.5 Chemcaps Limited
10.6 Fortcaps Healthcare
10.7 HealthCaps India
10.8 Lonza Group
10.9 Medi-Caps
10.10 Nectar Lifesciences
10.11 Qualicaps
10.12 Shanxi JC Biological Technology
10.13 Suheung
10.14 Sunil Healthcare
